Optiray 300
Active substance: ioversol
INJECTION · IOVERSOL 636 mg/mL
United StatesActive
Marketing holder: Liebel-Flarsheim Company LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- IOVERSOL · 636 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-66e2-76bf-8e9a-0093ad915751,01a12098-c159-79b6-bc85-cfb4ee18bc56,01a12098-c193-7897-88ff-7eb0c6e3def4;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0019-1332
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRA-ARTERIAL, INTRAVENOUS
Sources
- product · openFDA NDC · 0019-1332 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0019-1332 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0019-1332 · Verified 2026-10-09 · open in source